The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.
Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism
Abstract
Extensive animal studies suggest neuropeptide Y (NPY) to be involved in coping with a wide range of stressors, and that impaired central NPY signalling could be involved in the pathophysiology of anxiety and depression. Human studies of central NPY levels in depression have, however, been inconclusive. Here, we examined levels of NPY-like immunoreactivity (NPY-LI) in the cerebrospinal fluid (CSF) of medication-free subjects with treatment refractory unipolar depression. Patients were admitted to a research inpatient unit, examined under standardized conditions, and compared with a sample of volunteers in whom psychiatric morbidity was excluded. A robust suppression of NPY levels in patient CSF was found, while other putative CSF markers (monoamine metabolites, somatostatin) did not differ between the groups. We then explored whether this finding might be related to a recently described T1128C coding polymorphism which results in a Leu7-> Pro7 substitution of the signal peptide, and a previously not described T -399C polymorphism in the promoter region of the preproNPY gene. Preliminary evidence was found for an association of both markers with a diagnosis of depression, indicating the possibility of an underlying haplotype influencing the vulnerability for developing depressive illness. Our present findings are in line with an extensive animal literature, and further support the notion that impaired NPY function could contribute to depressive illness.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Low NPY levels have been reported in MDD compared to healthy controls153, and genetic variation associated with low NPY expression increases risk for MDD153,154.”
From Psychobiological factors of resilience and depression in late life (2019) · cites this paper as [153]
Citations
Cites
A Diagnostic Interview: The Schedule for Affective Disorders and Schizophrenia
Endicott, J. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770310043002 · Cited by 5,684
Tatemoto, K., Carlquist, M., & Mutt, V. (1982) · Nature · doi:10.1038/296659a0 · Cited by 2,269 · cited 1×
“Neuropeptide Y (NPY) (Tatemoto et al., 1982) is a 36 amino acid peptide abundantly present in the mammalian nervous system.”
BackgroundAllostasis and Allostatic Load Implications for Neuropsychopharmacology
McEwen, B. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00129-3 · Cited by 1,833
MERRITT, H. H., FREMONT-SMITH, F., & AYER, J. B. (1938) · The American Journal of the Medical Sciences · doi:10.1097/00000441-193804000-00024 · Cited by 875
Modulation of Anxiety and Neuropeptide Y-Y1 Receptors by Antisense Oligodeoxynucleotides
Wahlestedt, C., Pich, E. M., Koob, G. F., Yee, F., & Heilig, M. (1993) · Science · doi:10.1126/science.8380941 · Cited by 527 · cited 1×
“Agonist, antagonist and antisense oligonucleotide studies (Heilig et al., 1993; Sajdyk et al., 1999; Wahlestedt et al., 1993; Heilig, 1995) consistently indicate that this action of NPY is mediated through an activation of Y1 receptors.”
BackgroundSelf-citationEndicott, J. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780260100011 · Cited by 428
Heilig, M., S�derpalm, B., Engel, J. A., & Widerl�v, E. (1989) · Psychopharmacology · doi:10.1007/bf00441953 · Cited by 390
Self-citationThe neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y
Kask, A., Harro, J., von Hörsten, S., Redrobe, J. P., Dumont, Y., & Quirion, R. (2002) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(01)00066-5 · Cited by 358
Heilig, M., McLeod, S., Brot, M., Heinrichs, S. C., Menzaghi, F., Koob, G. F., & Britton, K. T. (1993) · Neuropsychopharmacology · doi:10.1038/npp.1993.35 · Cited by 356
Self-citationCorticotropin-releasing factor and neuropeptide y: role in emotional integration
Heilig, M., Koob, G. F., Ekman, R., & Britton, K. T. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90079-5 · Cited by 324
Self-citation
Research works printed but not linked: 1
- Gottfries, 1995, Neuropeptides and Alzheimers disease, European Neuropsychopharmacology, 5, 491, 10.1016/0924-977x(95)00038-q · doi:10.1016/0924-977x(95)00038-q
Cited by
Russo, S. J., Murrough, J. W., Han, M.-H., Charney, D. S., & Nestler, E. J. (2012) · Nature Neuroscience · doi:10.1038/nn.3234 · Cited by 1,206
The Genetics of Major Depression
Flint, J., & Kendler, K. S. (2014) · Neuron · doi:10.1016/j.neuron.2014.01.027 · Cited by 724
“Two SNPs (in C5orf20 [Willis-Owen et al., 2006] and in NPY [Heilig et al., 2004]) scored p values less than 0.05, where four would have been expected by chance.”
InfluentialThe NPY system in stress, anxiety and depression
Heilig, M. (2004) · Neuropeptides · doi:10.1016/j.npep.2004.05.002 · Cited by 614
Self-citationMillan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Meta-analyses of genetic studies on major depressive disorder
López-León, S., Janssens, A. C. J. W., González-Zuloeta Ladd, A. M., Del-Favero, J., Claes, S. J., Oostra, B. A., & van Duijn, C. M. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002088 · Cited by 493
Metadata
- Authors
- Heilig, M., Zachrisson, O., Thorsell, A., Ehnvall, A., Mottagui-Tabar, S., Sjögren, M., Åsberg, M., Ekman, R., Wahlestedt, C., & Ågren, H.
- Affiliations
- Karolinska Institutet (SE)
- Sahlgrenska University Hospital (SE)
- Scripps Research Institute (US)
- Corresponding author
- Heilig, Markus
- ORCID
- Venue
- Journal of Psychiatric Research
- Publisher
- Elsevier BV
- Published
- 2004-03
- Volume
- 38
- Issue
- 2
- Pages
- 113-121
- ISSN
- 0022-3956 (ISSN-L)
- OpenAlex
- W2001237798
- Cited by
- 177
- References
- 54
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 4 · 2022: 9 · 2021: 5 · 2020: 5 · 2019: 10 · 2018: 4 · 2017: 5 · 2016: 4 · 2015: 6 · 2014: 13 · 2013: 10 · 2012: 18
- FWCI
- 2.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Journal of Psychiatric Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Vetenskapsrådet
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- neuropeptide Y, cerebrospinal fluid, treatment-resistant depression, unipolar major depression, genetic polymorphism, monoamine metabolites, somatostatin, genetic susceptibility to depression, haplotypes
- MeSH terms
- Adult, Aged, Depressive Disorder, Drug Resistance, Female, Humans, Male, Middle Aged, Neuropeptide Y, Polymorphism, Genetic, Protein Precursors, Recurrence, Biomarkers, Case-Control Studies, Polymerase Chain Reaction, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism. https://app.cochat.ai/papers/10.1016/s0022-3956(03)00101-8
- The paper
- Heilig, M., Zachrisson, O., Thorsell, A., Ehnvall, A., Mottagui-Tabar, S., Sjögren, M., Åsberg, M., Ekman, R., Wahlestedt, C., & Ågren, H. (2004). Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism. Journal of Psychiatric Research. https://doi.org/10.1016/s0022-3956(03)00101-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.